|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.3 USD | +1.94% |
|
-4.40% | -10.00% |
| Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
| Mar. 29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Kala Pharmaceuticals, Inc. announced Robert Paull not stand for re-election as a Director at the AGM to be held on June 22, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.00% | 17.74M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
KALA BIO, INC. 
